Feasibility and acceptability of the delivery of a group telehealth intervention for support persons of patients receiving buprenorphine for opioid use disorder

被引:0
|
作者
Ueland, Elizabeth [1 ]
Nameth, Katherine [1 ]
Manuel, Jennifer K. [2 ,3 ]
Osilla, Karen Chan [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 1070 Arastradero Rd, Palo Alto, CA 94304 USA
[2] San Francisco VA Hlth Care Syst, 4150 Clement St, San Francisco, CA 94121 USA
[3] Univ Calif San Francisco, Dept Psychiat & Behav Sci, 675 18th St, San Francisco, CA 94143 USA
关键词
Opioid use disorders; CRAFT; Family; Buprenorphine; COMMUNITY REINFORCEMENT; TELEMEDICINE; INDIVIDUALS; EFFICACY; FAMILIES; ALCOHOL; ACCESS; CRAFT; CARE;
D O I
10.1016/j.josat.2025.209628
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Opioid-related overdoses increased substantially during the COVID-19 pandemic, eliciting an urgent demand for accessible treatment for individuals with opioid use disorder (OUD) and those who support them (support persons). Support persons can improve treatment initiation and retention in their individuals with OUD. Additionally, support persons may have their own mental health needs related to their loved one's OUD. Unfortunately, few treatment options exist for support persons of individuals with an OUD. A support personfocused group telehealth intervention (referred to as eINSPIRE) that is accessible and feasible could help fill the treatment gap for support persons and bolster outcomes for individuals with OUD. Methods: The study interviewed patients receiving buprenorphine (n = 9), their support persons (n = 12), and clinic staff members (n = 6) about their perceptions on a group telehealth intervention designed for support persons. Patient and support person dyads were recruited from two community health clinics to participate in a qualitative interview and/or focus group. Using classic content analysis, we then analyzed this data to evaluate the feasibility, acceptability, and usability of a group telehealth intervention for support persons. Results: The eINSPIRE intervention was deemed generally acceptable, feasible, and usable. All support persons (n = 12) agreed that group telehealth was acceptable and those who completed an eINSPIRE demo session found it usable (IUS = 72.5). Patients indicated that eINSPIRE would be beneficial for support persons, and could provide services that are unattainable to them in their immediate community, but that groups sometimes lacked intimacy. Participants also found group telehealth to be more accessible than in-person alternatives and suggested how to improve the delivery of the intervention. Conclusions: Group telehealth may be a feasible and acceptable option for delivering an intervention to support persons and could reduce barriers to treatment that this population often experiences due to competing demands. However, due to sample size limitations, more participant perspectives and future research are needed.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Acute Pain Management for Patients with Substance Use Disorder Receiving Buprenorphine or Methadone Compared to Patients without Opioid-Dependence Disorder
    Vogler, Carrie
    Arnold, Stephen
    Surbeck, Erin
    Conklen, Katelyn
    Deshpande, Maithili
    JOURNAL OF PAIN & PALLIATIVE CARE PHARMACOTHERAPY, 2022, 35 (04) : 260 - 263
  • [42] Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosis
    Kever, Anne
    Aguerre, Ines M.
    Vargas, Wendy
    Straus Farber, Rebecca
    Levine, Libby
    Riley, Claire S.
    Vasquez, Minnelly
    Leavitt, Victoria M.
    CLINICAL REHABILITATION, 2022, 36 (10) : 1305 - 1313
  • [43] Induction With Microdoses of Buprenorphine Perioperatively in Opioid Use Disorder Patients Undergoing Surgical Intervention for Infective Endocarditis
    Book, George A.
    Smith, Allison
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S191 - S191
  • [44] Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine
    Stein, Michael D.
    VanNoppen, Donnell
    Herman, Debra S.
    Anderson, Bradley J.
    Conti, Micah
    Bailey, Genie L.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 136
  • [45] A Resident-Led Intervention to Increase Initiation of Buprenorphine Maintenance for Hospitalized Patients With Opioid Use Disorder
    Thakrar, Ashish P.
    Furfaro, David
    Keller, Sara
    Graddy, Ryan
    Buresh, Megan
    Feldman, Leonard
    JOURNAL OF HOSPITAL MEDICINE, 2021, 16 (06) : 339 - 344
  • [46] Early findings on home delivery of buprenorphine and retention in treatment for opioid use disorder
    Lira, Marlene C.
    Hendy, Lauren E.
    Liakas, Alisha
    Turanchik, Laura
    Pritchard, Clare
    Jimes, Cynthia
    Coffey, M. Justin
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2025, 20 (01):
  • [47] Aftercare for adolescent alcohol use disorder: Feasibility and acceptability of a phone intervention
    Burleson, Joseph A.
    Kaminer, Yifrah
    AMERICAN JOURNAL ON ADDICTIONS, 2007, 16 (03): : 202 - 205
  • [48] Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder
    White, Augustus M.
    Eglovitch, Michelle
    Parlier-Ahmad, Anna Beth
    Dzierzewski, Joseph M.
    James, Morgan
    Bjork, James M.
    Moeller, F. Gerard
    Martin, Caitlin E.
    PLOS ONE, 2024, 19 (06):
  • [49] Telehealth Delivery of Opioid Use Disorder Treatment in the Age of Covid-19
    Lin, Lewei
    Moore, David
    Kan, David
    Mooney, Larissa
    Moustafa, Yara
    Pakhdikian, Sarin
    Ruchelli, Gabriela
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 226 - 227
  • [50] Urban-rural differences in mortality among patients receiving buprenorphine for opioid use disorder treatment in Kentucky
    Lei, Feitong
    Freeman, Patricia R.
    Slavova, Svetla
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 402 - 403